Health

Serum Institute of India to produce Sputnik V in India from September

After the successful development of Covishield, Serum Institute of India (SII) has now joined hands with Russian Direct Investment Fund (RDIF) for the production of Sputnik V Covid-19 vaccine. According to a joint statement released on July 13, the first batch of Sputnik V doses will be produced at SII’s facilities in September.

As  part of the technical transfer process, the Pune-based biotechnology company has already received cell and vector samples from Gamaleya Center located in Moscow. “With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun,” said RDIF.

Kirill Dmitriev, CEO of RDIF said, “This strategic partnership is a major step to substantially increase our production capabilities demonstrating a perfect example of joining forces and expertise to save lives both in India and around the world.”

The two parties – SII and RDIF, aim to produce more than 300 million doses of Sputnik V vaccine in India per year. However, this is not the first time that  Russia’s sovereign wealth fund has come into an agreement with an Indian pharmaceutical institute. Morepen, Gland Pharma, Hetero Biopharma and Stelis Biopharma are some of the companies that it had  earlier reached agreements with.

Dr Reddy’s Laboratories, on the other hand, holds the sole distribution rights for the first 250 million doses of Sputnik V in the country. It soft-launched the vaccine on May 14 and has expanded the distribution to over 50 cities and towns across India so far.

Globally, the Russian Sputnik V vaccine has been registered in over 67 countries that amount to around 3.5 billion people. According to the data obtained by regulators of countries like Argentina, Hungary, Mexico, the UAE and Serbia, it is deemed as one of the safest and most effective vaccines against Covid-19.

Andrew s

Andrew has been in the online publishing industry. After receiving his degree in professional journalism from the Indian Institute of Journalism and New Media, he contributed to multiple websites as a freelance writer and feature editor. Mostly, Andrew tackles controversies and theories that lead to a specific conclusion that either debunk or justify a particular claim. Further, Andrew participates in social developments that aim to simplify every individual's way of life and fight for peace. He is the new Editor-in-Chief of Pressroom Today.

Share
Published by
Andrew s

Recent Posts

IPL 2024 Kicks Off In Style: All-Star Teams Prepare to Play for the Cup

The popular sports league, which garners significant viewership from India and abroad, has initiated its…

7 hours ago

Lok Sabha Elections 2024: India’s Future Awaits ‘Saath Phase Paar’

The total number of registered voters is more than the combined population of all European…

1 week ago

Scam 2024: The Electoral Bonds Scheme And Its Top Contributors Come to Light

Who paid whom, how much and WHY? These are the general questions that everyone asked…

2 weeks ago

Centre Notifies Rules for CAA: Stirs the Indian Political Arena Across Different Levels

The new legislation aims to uplift persecuted minorities by granting them Indian citizenship based on…

2 weeks ago

Centre Notifies Rules for CAA: Stirs the Indian Political Arena Across Different Levels

The new legislation aims to uplift persecuted minorities by granting them Indian citizenship based on…

2 weeks ago

Daman Game: Where Fun Meets Real Rewards

Online gaming has found a vast audience among the youth who are most of the…

3 weeks ago